Φορτώνει......
Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine
BACKGROUND: DNA vaccines have emerged as an attractive approach for the generation of cytotoxic T lymphocytes (CTL). In our previous study, we found That Toll like receptor (TLR) ligands are promising candidates for the development of novel adjuvants for DNA vaccine. To improve the efficacy of DNA v...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Biomed Sci |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4727273/ https://ncbi.nlm.nih.gov/pubmed/26811064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-016-0238-3 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|